ADAM17 and Obesity: In contrast to our findings and the other data noted above that implicate various whole-body ADAM17 mutants in hypermetabolism [38], Lownik and colleagues observed that deletion of ADAM17 in adipose tissues had little impact on whole-body metabolism and inflammation in HFD-triggered obesity [104].